NAMS
NAMS
NASDAQ · Biotechnology

Newamsterdam Pharma Co Nv

$18.90
+0.01 (+0.05%)
As of Nov 7, 1:33 AM ET ·
Next Earnings Report
Nov 11, 2026
Before Market Open
3 days away
EPS Estimate $-0.52
Revenue Est $7.49M
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
Aug 12, 2026 Q3 FY2026 $-0.50 — — — —
May 7, 2026 Q2 FY2026 $-0.50 — — — —
Mar 4, 2026 Q1 FY2026 $-0.39 — — — —